Abstract:FMEA was useful for detecting medication errors in the PN preparation process and enabling corrective measures to be taken. A checklist was developed to reduce errors in the most critical aspects of the process.
“…Applying method insights resulted in a remarkable organizational attitude and practice shift towards a top safety level. Our work, similarly to other studies using FMEA methodology [15, 16], showed that FMEA prioritizes the potential harms and minimizes riskiness of complex processes.Fig 2The cascade of methodology- process- outcome
…”
BackgroundIntravenous potassium chloride (IV KCl) solutions are widely used in hospitals for treatment of hypokalemia. As ampoules of concentrated KCL must be diluted before use, critical incidents have been associated with its preparation and administration. Currently, we have introduced ready-to-use diluted KCl infusion solutions to minimize the use of high-alert concentrated KCl. Since this process may be associated with considerable risks, we embraced a proactive hazard analysis as a tool to implement a change in high-alert drug usage in a hospital setting.MethodsFailure mode and effect analysis (FMEA) is a systematic tool to analyze and identify risks in system operations. We used FMEA to examine the hazards associated with the implementation of the ready-to-use solutions. A multidisciplinary team analyzed the risks by identifying failure modes, conducting a hazard analysis and calculating the criticality index (CI) for each failure mode. A 1-day survey was performed as an evaluation step after a trial run period of approximately 4 months.ResultsSix major possible risks were identified. The most severe risks were prioritized and specific recommendations were formulated. Out of 28 patients receiving IV KCl on the day of the survey, 22 received the ready-to-use solutions and 6 received the concentrated solutions as instructed. Only 1 patient received inappropriate ready-to-use KCl.ConclusionsUsing the FMEA tool in our study has proven once again that by creating a gradient of severity of potential vulnerable elements, we are able to proactively promote safer and more efficient processes in health care systems. This article presents a utilization of this method for implementing a change in hospital policy regarding the routine use of IV KCl.
“…Applying method insights resulted in a remarkable organizational attitude and practice shift towards a top safety level. Our work, similarly to other studies using FMEA methodology [15, 16], showed that FMEA prioritizes the potential harms and minimizes riskiness of complex processes.Fig 2The cascade of methodology- process- outcome
…”
BackgroundIntravenous potassium chloride (IV KCl) solutions are widely used in hospitals for treatment of hypokalemia. As ampoules of concentrated KCL must be diluted before use, critical incidents have been associated with its preparation and administration. Currently, we have introduced ready-to-use diluted KCl infusion solutions to minimize the use of high-alert concentrated KCl. Since this process may be associated with considerable risks, we embraced a proactive hazard analysis as a tool to implement a change in high-alert drug usage in a hospital setting.MethodsFailure mode and effect analysis (FMEA) is a systematic tool to analyze and identify risks in system operations. We used FMEA to examine the hazards associated with the implementation of the ready-to-use solutions. A multidisciplinary team analyzed the risks by identifying failure modes, conducting a hazard analysis and calculating the criticality index (CI) for each failure mode. A 1-day survey was performed as an evaluation step after a trial run period of approximately 4 months.ResultsSix major possible risks were identified. The most severe risks were prioritized and specific recommendations were formulated. Out of 28 patients receiving IV KCl on the day of the survey, 22 received the ready-to-use solutions and 6 received the concentrated solutions as instructed. Only 1 patient received inappropriate ready-to-use KCl.ConclusionsUsing the FMEA tool in our study has proven once again that by creating a gradient of severity of potential vulnerable elements, we are able to proactively promote safer and more efficient processes in health care systems. This article presents a utilization of this method for implementing a change in hospital policy regarding the routine use of IV KCl.
Background: Medication errors represent a significant but often preventable cause of morbidity and mortality in neonates. The objective of this systematic review was to determine the effectiveness of interventions to reduce neonatal medication errors. Methods: A systematic review was undertaken of all comparative and noncomparative studies published in any language, identified from searches of PubMed and EMBASE and referencelist checking. Eligible studies were those investigating the impact of any medication safety interventions aimed at reducing medication errors in neonates in the hospital setting. Results: A total of 102 studies were identified that met the inclusion criteria, including 86 comparative and 16 noncomparative studies. Medication safety interventions were classified into six themes: technology (n = 38; e.g. electronic prescribing), organizational (n = 16; e.g. guidelines, policies, and procedures), personnel (n = 13; e.g. staff education), pharmacy (n = 9; e.g. clinical pharmacy service), hazard and risk analysis (n = 8; e.g. error detection tools), and multifactorial (n = 18; e.g. any combination of previous interventions). Significant variability was evident across all included studies, with differences in intervention strategies, trial methods, types of medication errors evaluated, and how medication errors were identified and evaluated. Most studies demonstrated an appreciable risk of bias. The vast majority of studies (>90%) demonstrated a reduction in medication errors. A similar median reduction of 50-70% in medication errors was evident across studies included within each of the identified themes, but findings varied considerably from a 16% increase in medication errors to a 100% reduction in medication errors. Conclusion: While neonatal medication errors can be reduced through multiple interventions aimed at improving the medication use process, no single intervention appeared clearly superior. Further research is required to evaluate the relative cost-effectiveness of the various medication safety interventions to facilitate decisions regarding uptake and implementation into clinical practice.
“…Asefzadeh (2011) in his study identified 48 potential failure modes using FMEA and found that the highest PRN in the respiratory care process was related to the inactive alarm system of the ventilator (PRN = 288); negligence and malpractice, the lack of providing proper training to the employees, and employees' fatigue caused were the cause (21). In their study, Arenas Villafranca et al (2014) (22) found 82 potential failure modes. The processes with the highest PRNs were transcription of the medication orders, formulation of the neonatal parenteral nutrition, and preparation of materials for the formulation.…”
Background: Neonatal intensive care units are prone to a variety of errors due to their special conditions. Failure mode and effects analysis (FMEA) is a method for risk assessment and management, which assesses the safety of patient care processes through its system approach. Objectives: The present study aimed to identify and assess common medical errors at Amirkola Children's hospital NICU in 2016. Methods: This was a cross-sectional study conducted from September 2015 to February 2016 in the NICU of Amirkola Children's Hospital in the city of Babol to identify and assess the medical errors and their effects qualitatively and quantitatively using FMEA through direct observations of the NICU processes, brainstorming, and focus group discussions (FGD). The FMEA standard worksheet was used for data collection. The collected data were analyzed using Excel 2010. Results: In this study, 4 key processes were selected through studying the care methods and brainstorming including drug administration, infection control, medical equipment use, and laboratory tests; 27 activities and 50 potential failure modes, as well as their impacts were detected and recorded in the final worksheet of FMEA. According to the calculated PRNs, 27 potential failure modes with PRN > 65 were determined as high-risk failures. The highest and lowest PRNs were, respectively, related to improper and incomplete washing and disinfecting the hands (PRN = 127) and illegibility of the lab requests for laboratory tests (PRN = 32). Conclusions: Based on the findings of this study, 57 potential failure modes in 4 key processes of the studied NICU were determined, among which 27 potential errors and failures with high risks were recognized. Therefore, it can be suggested that the senior managers and administrators should create multidisciplinary teams for patient safety at the organizational and unit levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
